TPG to Present at the BofA Securities 2024 Financial Services Conference
TPG Inc. (NASDAQ: TPG), a leading global alternative asset management firm, announced today that Jack Weingart, Chief Financial Officer, is scheduled to present at the BofA Securities 2024 Financial Services Conference on Wednesday, February 21, 2024 at 9:40 a.m. ET.
A live audio webcast of the discussion will be available on the Investor Relations section of TPG's website at shareholders.tpg.com/events-presentations/events. For those unable to listen to the live webcast, a replay will be available on the Events page of TPG's website shortly after the event.
About TPG
TPG is a leading global alternative asset management firm, founded in San Francisco in 1992, with $222 billion of assets under management and investment and operational teams around the world. TPG invests across a broadly diversified set of strategies, including private equity, impact, credit, real estate, and market solutions, and our unique strategy is driven by collaboration, innovation, and inclusion. Our teams combine deep product and sector experience with broad capabilities and expertise to develop differentiated insights and add value for our fund investors, portfolio companies, management teams, and communities.
China and Kazakhstan have always supported each other and have always been partners in times of challenges, Chinese President Xi Jinping said in a signed article in the Kazakhstanskaya Pravda newspaper and Kazinform International News Agency on...
H.I.G. Capital ("H.I.G."), a leading global alternative investment firm with $64 billion of capital under management, is pleased to announce that an affiliate has signed a definitive agreement to acquire CGH Group S.A. ("CGH" or the "Company"), a...
Truecaller, the leading global platform for verifying contacts and blocking unwanted communication, is publishing its interim report for January-June on Friday 19 July 2024 at 07.30 CET.
Alan Mamedi, CEO and Odd Bolin, CFO presents the report and...
Calliditas Therapeutics AB (STO: CALTX) ("Calliditas") today announces that its partner Viatris Pharmaceutical Japan G.K. ("Viatris") has initiated a phase III clinical trial in Japan with Nefecon, named VR-205 in the Japanese market, in Japanese...
China and Kazakhstan have always supported each other and have always been partners in times of challenges, Chinese President Xi Jinping said in a signed article in the Kazakhstanskaya Pravda newspaper and Kazinform International News Agency on...
